Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
new york blog main
new york top stories
4
×
boston blog main
boston top stories
clinical trials
national top stories
pfizer
san francisco blog main
san francisco top stories
biotech
breast cancer
gene therapy
glaxosmithkline
new york
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
spark therapeutics
abbvie
acute migrane
adverum biotechnologies
akcea therapeutics
albert bourla
alzheimer's disease
amgen
amicus therapeutics
anylam pharmaceuticals
arvinas
bain capital
batten disease
bausch health
bayer
biogen
biomarin
boulder/denver blog main
boulder/denver top stories
brian stuglik
What
pfizer
4
×
drug
patients
acquisitions
activity
ago
akcea
albert
alnylam
amyloidosis
approved
attr
available
battle
biggest
bio
biotech
bourla
ceo
close
companies
company
crispr
data
days
debilitating
disease
dog
fda
firm
forward
future
gene
genetic
hasn’t
heated
hemophilia
imports
ipo
ipos
Language
unknown
unset
Current search:
pfizer
×
" new york top stories "
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea